explore -WSS

explore

author：leisure time 2025-09-29 23:28:07 - browse：338

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Doctor appointment wait times are getting worse

hotspot

WSS

FDA approves first new drug developed for postpartum depression

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Make 'food is medicine' a key part of White House nutrition meeting

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Inside the fall of star MIT scientist David Sabatini

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

hotspot

explore

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Medical leaders decry Supreme Court decision on affirmative action

Listen: Biogen's messy board & Laronde's data problem

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Inside the rise of 'mukbang' eating videos

Bright Health sells Medicare Advantage business to Molina

Timeline: Key moments in fight for gay rights

23andMe had bad news about my health. I wish a person had delivered it

Timeline: Key moments in fight for gay rights

knowledge

Did the public have the right to know Arthur Ashe had AIDS?

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Listen: Biogen's messy board & Laronde's data problem

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Bispecific antibodies are next new thing in cancer immunotherapy

Make 'food is medicine' a key part of White House nutrition meeting

entertainment

Wikipedia

hotspot

explore